Charlée Nardin
Inserm(FR)Université de franche-comté(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, CAR-T cell therapy research, Immunotherapy and Immune Responses, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study(2018)277 cited
- → Tracking the evolution of circulating exosomal‐PD‐L1 to monitor melanoma patients(2020)253 cited
- → Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry*(2020)88 cited
- → Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases(2018)57 cited
- → Vitiligo under anti–programmed cell death-1 therapy is associated with increased survival in melanoma patients(2019)40 cited
- → Increased Levels of Interleukin-17A Exosomes in Psoriasis(2019)39 cited
- → Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pH(2018)38 cited
- → Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study(2023)37 cited
- → Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients(2021)33 cited
- → Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study(2021)30 cited